Login to Your Account



Spirogen Takes Back Cancer Drug, Gets $15M for New Trials

By Nuala Moran


Wednesday, October 14, 2009
No Abstract

To continue reading subscribe now to BioWorld International

Learn More about BioWorld International

Already a subscriber? Sign In or Buy now to activate your subscription